Caprock Group
CSII

Caprock Group’s Cardiovascular Systems, Inc. CSII Stock Holding History

Caprock Group’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-8,380
Closed -$237K – 476
2017
Q1 		$237K Hold
8,380
– – 0.06% 294
2016
Q4 		$203K Buy
+8,380
New +$206K 0.05% 311

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Caprock Group's CSII Position: Q2 2017 in Review

Caprock Group sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2017, closing a stake of 8,380 shares — an estimated $237K sold.

Caprock Group first reported a position in CSII in Q4 2016 and held it in 2 quarters. The position peaked at $237K in Q1 2017. 157 funds tracked by Wall St. Rank hold CSII as of Q2 2017.

  • Caprock Group reported no remaining Cardiovascular Systems, Inc. position as of Q2 2017 after selling out during the quarter.
  • Caprock Group sold 8,380 Cardiovascular Systems, Inc. shares in Q2 2017, an estimated $237K.
  • Caprock Group first reported a position in Cardiovascular Systems, Inc. in Q4 2016 and held it in 2 quarters.
  • Caprock Group's Cardiovascular Systems, Inc. position peaked at $237K in Q1 2017.
  • 157 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2017.

Based on Caprock Group's 13F filing for Q2 2017, filed 27 Jul 2017.